The 3rd Middle East Society for Radiation Oncology Congress (MESTRO) Conference 2024 will take place at Alfaisal University Riyadh, Saudi Arabia 27-29 November. 

This year, SGRT will be partnering with MESTRO for half-day event, held on 28 November 2024 From Innovation to Necessity” and will feature experienced users of Surface Guided Radiation Therapy presenting on all aspects of the use of SGRT. It will also bring Far Asia from Japan participation to The Federation of Asian Organizations for Radiation Oncology (FARO). 

The Congress will build a regional and international networking, collaboration, education and more, in various oncological disciplines. This includes but is not limited to Radiation Professionals, Radiation Oncologists, Medical Oncologists, Medical Physicists, Dosimetrists, Radiation Therapists (RTTs), Clinical Engineers and allied Oncology specialties including Nurse. This will bring lots of opportunities from education to investment in health care.

Highlights of the conference include:

• International keynote speakers addressing cutting-edge studies and technologies.

• Expert regional and national speakers.

• Updates of Radiation Oncology status in regional countries.

• Educational opportunities.

• CME accreditation, 26 hours.

• Sessions on Breast, Head & Neck, Gastro-intestinal, Genito-urinary, Gynecological, Pediactric, lung, CNS, and other

cancers.

• Presentations on Immunotherapy.

• Extensive brachytherapy and Stereotactic radiotherapy sessions.

• Brachytherapy workshop.

• Multidisciplinary subcommittee discussions in multiple cancer sites.

• Separate parallel sessions for Physicists and Radiation Therapists (RTTs).

• Hands on training / demo in contouring, trans-perineal prostate biopsy, hydrogel spacer and more.

To learn more about the Conference and registration: https://mestro.org/

X account: https://x.com/Mestro_Org

link for SGRT program Lhttps://sgrt.org/upcoming-meetings/sgrt-mestro-2024/

 

Saad Alrashidi, MD FRCPC DRCPSC

Chairman of the board, Middle East Society for Therapeutic Radiation Oncology (MESTRO)